Alexander Rich

This inventor holds 22 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent, primarily in Biotechnology. Top assignees: Massachusetts Institute of Technology, Tufts University, Wellesley College. Active years: 1983-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Rich. Retrieved from https://idiyas.com/inventor/alexander-rich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 1)

% Patents Active = 90.9

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.0

ph-index = 12

Forward Citations = 731(Granted Patents)

Location History:

Middlesex, MA (US) (1999)
Cambridge, MA (US) (1983 - 2018)

Company Filing History:

14 out of 8,586

Massachusetts Institute of Technology

New England Medical Center Hospitals. Inc.

University of Montreal

patents

7. 1 out of 2,164

Arizona State University

patents

8. 1 out of 14

New England Medical Center

patents

9. 1 out of 110

Ribozyme Pharmaceuticals, Incorporated

patents

10. 1 out of 1,168

Yeda Research and Develpment & Co. Ltd

patents

11. 4 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1983-2018

Loading Chart...

Areas of Expertise:

Water Soluble Proteins

Nucleozymes

Gene Expression Regulation

Self-Assembly

Biologically Active Fragments

Interleukin-1

Amphiphilic Peptides

Pharmaceutical Agents

Cell Patterning

Infectious Agents

Recombinant DNA

Z-DNA Binding Protein

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10035837 - Water soluble membrane proteins and methods for the preparation and use thereof (2018-07-31),

2. 9309302 - Water soluble membrane proteins and methods for the preparation and use thereof (2016-04-12),

3. 8637452 - Water soluble membrane proteins and methods for the preparation and use thereof (2014-01-28),

4. 7098028 - Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor (2006-08-29),

5. 7074601 - Nucleozymes (2006-07-11),

6. 7001718 - Method of inhibiting pathogenicity of infectious agents (2006-02-21),

7. 6800481 - Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor (2004-10-05),

8. 6713456 - Nucleozymes (2004-03-30),

9. 6548630 - Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor (2003-04-15),

10. 6368877 - Self-assembling peptide surfaces for cell patterning and interactions (2002-04-09),

11. 6140491 - Nucleozymes (2000-10-31),

12. 5998578 - Biologically active fragments of IL-1.beta. (1999-12-07),

13. 5985657 - Recombinant DNA which codes for interleukin-1 (1999-11-16),

14. 5955343 - Stable macroscopic membranes formed by self-assembly of amphiphilic (1999-09-21),

15. 5726050 - Z-DNA binding protein and applications (1998-03-10),

Title: Alexander Rich: Pioneer in Biotechnology

Introduction:

Alexander Rich, a renowned inventor in the field of biotechnology, has left an indelible mark on scientific progress. His innovative work has not only expanded our knowledge but has also significantly impacted the lives of many individuals. Hailing from Cambridge, MA, his legacy as an inventor and innovator continues to inspire future generations of scientists.

Latest Patents:

With an impressive portfolio of 22 patents, Alexander Rich's latest inventions include groundbreaking methods for preparing water-soluble membrane proteins. One of his key patents involves the creation of a water-soluble variant of a G-protein coupled receptor (GPCR), enhancing its efficacy and usability in various applications.

Career Highlights:

Throughout his illustrious career, Alexander Rich has been associated with esteemed institutions such as the Massachusetts Institute of Technology (MIT) where he has conducted groundbreaking research in the field of biotechnology. His contributions have earned him a reputation as a trailblazer in the scientific community.

Collaborations:

In his pursuit of innovation, Alexander Rich has collaborated with leading experts in the field, including notable coworkers such as Shuguang Zhang and Curtis A Lockshin. These collaborations have fostered a dynamic exchange of ideas and propelled advancements in biotechnology.

Conclusion:

In conclusion, Alexander Rich stands as a beacon of innovation in biotechnology, with a remarkable track record of patents and research that have redefined the boundaries of scientific exploration. His dedication to pushing the frontiers of knowledge serves as an inspiration to all those who seek to make a transformative impact in the field of biotechnology.

Profile summary based on public USPTO records.